Zai Lab (ZLAB) Tax Provisions (2025 - 2026)
Zai Lab (ZLAB) posted quarterly Tax Provisions of $1.4 million for Q1 2026, up 149.2% on a QoQ basis from -$2.9 million in Q4 2025.
Zai Lab (ZLAB) Tax Provisions (2025 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Tax Provisions for 2 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- Quarterly Tax Provisions changed N/A year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (changed N/A YoY) and the FY2025 annual result came in at -$2.9 million, changed N/A from the prior year.
- Tax Provisions grew to $1.4 million in Q1 2026 per ZLAB's latest filing, from -$2.9 million in the prior quarter.
- Over the last five years, Tax Provisions for ZLAB reached as high as $1.4 million in Q1 2026 and fell as low as -$2.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.44 Mn |
| Dec 31, 2025 | -2.93 Mn |